Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide

M. Noda, H. Nakanishi, N. Akaike

Research output: Contribution to journalArticle

124 Citations (Scopus)

Abstract

In the present study, we found that amyloid-β peptide enhanced glutamate release from primary cultured rat microglia via the Na+-dependent glutamate transporter, which was activated by extracellular K+. Glutamate transport current was measured by a conventional whole-cell patch recording mode under voltage-clamp conditions. With the pipette solution containing 10 mM glutamate and 100 mM Na+, an increase of the external K+ concentration from 0 to 10 mM evoked an outward current, resulting from co-extrusion of glutamate and Na+. The inward current, reflecting forward glutamate transport, was also activated by external glutamate. Both these reverse and forward glutamate transport currents were three-fold greater in microglia incubated with a relatively low concentration of amyloid-β peptide (25-35) (5 μM) for four days. The glutamate-activated inward current was blocked by D,L-threo-β-hydroxyaspartate in a dose-dependent manner (ranging from 0.001 to 1 mM), but not by a high concentration of kainate (1 mM). The glutamate concentration released from microglia upon high-K+ stimulation was also significantly increased (up to 170 μM) after treatment with amyloid-β peptide (25-35). These results suggest that, at the pathological sites where extracellular K+ concentration may increase, the activation of microglia by amyloid-β peptide causes an increase in extracellular glutamate concentration via reverse glutamate transporter, and therefore this mechanism may contribute to the pathogenesis of neuronal dysfunction and death in Alzheimer's disease.

Original languageEnglish
Pages (from-to)1465-1474
Number of pages10
JournalNeuroscience
Volume92
Issue number4
DOIs
Publication statusPublished - Jun 1 1999

Fingerprint

Amino Acid Transport System X-AG
Amyloid beta-Peptides
Microglia
Glutamic Acid
Amyloid
Peptides
Kainic Acid
Patch-Clamp Techniques
Alzheimer Disease

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide. / Noda, M.; Nakanishi, H.; Akaike, N.

In: Neuroscience, Vol. 92, No. 4, 01.06.1999, p. 1465-1474.

Research output: Contribution to journalArticle

Noda, M. ; Nakanishi, H. ; Akaike, N. / Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide. In: Neuroscience. 1999 ; Vol. 92, No. 4. pp. 1465-1474.
@article{cfeec9e752224bac80c1d3720bdcd81b,
title = "Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide",
abstract = "In the present study, we found that amyloid-β peptide enhanced glutamate release from primary cultured rat microglia via the Na+-dependent glutamate transporter, which was activated by extracellular K+. Glutamate transport current was measured by a conventional whole-cell patch recording mode under voltage-clamp conditions. With the pipette solution containing 10 mM glutamate and 100 mM Na+, an increase of the external K+ concentration from 0 to 10 mM evoked an outward current, resulting from co-extrusion of glutamate and Na+. The inward current, reflecting forward glutamate transport, was also activated by external glutamate. Both these reverse and forward glutamate transport currents were three-fold greater in microglia incubated with a relatively low concentration of amyloid-β peptide (25-35) (5 μM) for four days. The glutamate-activated inward current was blocked by D,L-threo-β-hydroxyaspartate in a dose-dependent manner (ranging from 0.001 to 1 mM), but not by a high concentration of kainate (1 mM). The glutamate concentration released from microglia upon high-K+ stimulation was also significantly increased (up to 170 μM) after treatment with amyloid-β peptide (25-35). These results suggest that, at the pathological sites where extracellular K+ concentration may increase, the activation of microglia by amyloid-β peptide causes an increase in extracellular glutamate concentration via reverse glutamate transporter, and therefore this mechanism may contribute to the pathogenesis of neuronal dysfunction and death in Alzheimer's disease.",
author = "M. Noda and H. Nakanishi and N. Akaike",
year = "1999",
month = "6",
day = "1",
doi = "10.1016/S0306-4522(99)00036-6",
language = "English",
volume = "92",
pages = "1465--1474",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide

AU - Noda, M.

AU - Nakanishi, H.

AU - Akaike, N.

PY - 1999/6/1

Y1 - 1999/6/1

N2 - In the present study, we found that amyloid-β peptide enhanced glutamate release from primary cultured rat microglia via the Na+-dependent glutamate transporter, which was activated by extracellular K+. Glutamate transport current was measured by a conventional whole-cell patch recording mode under voltage-clamp conditions. With the pipette solution containing 10 mM glutamate and 100 mM Na+, an increase of the external K+ concentration from 0 to 10 mM evoked an outward current, resulting from co-extrusion of glutamate and Na+. The inward current, reflecting forward glutamate transport, was also activated by external glutamate. Both these reverse and forward glutamate transport currents were three-fold greater in microglia incubated with a relatively low concentration of amyloid-β peptide (25-35) (5 μM) for four days. The glutamate-activated inward current was blocked by D,L-threo-β-hydroxyaspartate in a dose-dependent manner (ranging from 0.001 to 1 mM), but not by a high concentration of kainate (1 mM). The glutamate concentration released from microglia upon high-K+ stimulation was also significantly increased (up to 170 μM) after treatment with amyloid-β peptide (25-35). These results suggest that, at the pathological sites where extracellular K+ concentration may increase, the activation of microglia by amyloid-β peptide causes an increase in extracellular glutamate concentration via reverse glutamate transporter, and therefore this mechanism may contribute to the pathogenesis of neuronal dysfunction and death in Alzheimer's disease.

AB - In the present study, we found that amyloid-β peptide enhanced glutamate release from primary cultured rat microglia via the Na+-dependent glutamate transporter, which was activated by extracellular K+. Glutamate transport current was measured by a conventional whole-cell patch recording mode under voltage-clamp conditions. With the pipette solution containing 10 mM glutamate and 100 mM Na+, an increase of the external K+ concentration from 0 to 10 mM evoked an outward current, resulting from co-extrusion of glutamate and Na+. The inward current, reflecting forward glutamate transport, was also activated by external glutamate. Both these reverse and forward glutamate transport currents were three-fold greater in microglia incubated with a relatively low concentration of amyloid-β peptide (25-35) (5 μM) for four days. The glutamate-activated inward current was blocked by D,L-threo-β-hydroxyaspartate in a dose-dependent manner (ranging from 0.001 to 1 mM), but not by a high concentration of kainate (1 mM). The glutamate concentration released from microglia upon high-K+ stimulation was also significantly increased (up to 170 μM) after treatment with amyloid-β peptide (25-35). These results suggest that, at the pathological sites where extracellular K+ concentration may increase, the activation of microglia by amyloid-β peptide causes an increase in extracellular glutamate concentration via reverse glutamate transporter, and therefore this mechanism may contribute to the pathogenesis of neuronal dysfunction and death in Alzheimer's disease.

UR - http://www.scopus.com/inward/record.url?scp=0033006151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033006151&partnerID=8YFLogxK

U2 - 10.1016/S0306-4522(99)00036-6

DO - 10.1016/S0306-4522(99)00036-6

M3 - Article

C2 - 10426500

AN - SCOPUS:0033006151

VL - 92

SP - 1465

EP - 1474

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

IS - 4

ER -